Impact of glucose in peritoneal dialysis: saint or sinner?

@article{Sitter2005ImpactOG,
  title={Impact of glucose in peritoneal dialysis: saint or sinner?},
  author={Thomas Sitter and Matthias Sauter},
  journal={Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis},
  year={2005},
  volume={25 5},
  pages={
          415-25
        }
}
Peritoneal dialysis (PD) solutions using glucose as osmotic agent have been used for more than two decades as effective treatment for patients with end-stage renal disease. Although alternative osmotic agents such as amino acids and macromolecular solutions, including polypeptides and glucose polymers, are now available, glucose is still the most widely used osmotic agent in PD. It has been shown to be safe, effective, readily metabolized, and inexpensive. On the other hand, it is widely… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition.

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2017

Dialysis Modality and Mortality in the Elderly: A Meta-Analysis.

  • Clinical journal of the American Society of Nephrology : CJASN
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers

Loading similar papers…